Difference between revisions of "Antileukoproteinase"
(Created page with "{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | Substrate pepti...") |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 44: | Line 44: | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:24, 10 March 2015
Antileukoproteinase | |
---|---|
Substrate peptide name | Antileukoproteinase |
Synonyms | Secretory leukocyte protease inhibitor |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Secreted |
Swissprot ID | P03973 |
Reactive glutamines | Q27, Q70 |
Reactive lysines | K14, K35, K46 |
Substrate sequence | WQCPGK |
Structure | 2Z7F |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:21687692 |
Notes | |